Misoprostol Exelgyn

Misoprostol, the active ingredient in Misoprostol Exelgyn, is a prostaglandin E1 analog presented as an oral formulation for oral use. It is employed to protect the gastric mucosa in patients taking NSAIDs and to induce uterine contractility for obstetric indications, addressing both gastrointestinal and reproductive health needs.

GNH USA supplies Misoprostol Exelgyn as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Misoprostol acts on prostaglandin pathways to provide gastroprotective and obstetric effects.

- Prevention of NSAID‑induced gastric ulcers: reduces ulcer risk by enhancing mucus production and decreasing gastric acid secretion. - Medical termination of pregnancy: induces uterine contractions and cervical softening to facilitate expulsion of pregnancy tissue. - Induction of labor: promotes cervical ripening and uterine activity to initiate childbirth. - Management of postpartum hemorrhage: stimulates uterine contraction to control bleeding after delivery.

Misoprostol may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Abdominal pain - Diarrhea - Nausea - Vomiting - Fever - Chills

Serious or Rare Side Effects: - Uterine rupture - Severe postpartum hemorrhage - Anaphylactic reaction - Cardiovascular collapse - Severe abdominal pain with peritonitis

When prescribing Misoprostol, clinicians should observe several safety measures.

- Assess ulcer risk: evaluate patient history of NSAID use and gastrointestinal disease. - Evaluate pregnancy status: confirm gestational age before obstetric use. - Review concomitant NSAID therapy: avoid high‑dose NSAIDs that may counteract protection. - Monitor uterine activity: observe for hyperstimulation during labor induction. - Adjust for organ impairment: consider dose modification in severe renal or hepatic dysfunction. - Store at below 25°C: keep in the original packaging, protect from moisture and light.

Misoprostol can interact with other medicines, altering its efficacy or safety.

Major Interactions (Avoid): - Concurrent use with other uterotonic agents (e.g., oxytocin, carboprost) may cause excessive uterine contraction. - Combination with anticoagulants (e.g., warfarin, heparin) can increase the risk of severe bleeding. - Co‑administration with high‑dose NSAIDs may diminish gastric protective effect.

Moderate Interactions (Monitor Closely): - Antacids containing aluminum or magnesium may reduce oral absorption of misoprostol. - Rifampin and other enzyme inducers can lower plasma concentrations, reducing effectiveness. - Corticosteroids may enhance gastrointestinal side effects when used together.